The World Health Organization (WHO) has sounded the alarm on the inadequacy of diagnostic tools and funding in the global fight against antimicrobial resistance. According to a report published on November 16, the WHO highlights persistent weaknesses in the response to this global health threat. Despite progress in the adoption of national strategies, the lack of funding, specialized laboratories, and surveillance mechanisms hampers an effective response.
A survey of 183 countries found that 173 now have a national plan to combat antimicrobial resistance, up from 79 in 2017. This increase reflects growing awareness among governments of the public health problem. However, having a national strategy does not guarantee its effective implementation. Only 22% of countries reported mobilizing necessary funding and fully executing their action plans.
The WHO report also notes significant gaps in diagnostic capabilities. Only 36% of countries have a national reference laboratory capable of analyzing relevant bacteria and fungi. This weakness complicates the identification of resistant infections and may lead to the administration of ineffective or inappropriate treatments.
The scale of antimicrobial resistance is alarming. In 2023, nearly one in six laboratory-confirmed bacterial infections worldwide showed resistance to antibiotics. The WHO is calling for increased investment in healthcare infrastructure, diagnostic capabilities, and surveillance systems to enable countries to better detect resistant infections and adapt treatments.
The consequences of inaction are severe. If left unchecked, antimicrobial resistance will undermine the effectiveness of treatments and patient care. The WHO emphasizes the need for sustained commitment and concrete action at the national and international levels to address this challenge.
The WHO's warning highlights the need for urgent action to strengthen healthcare systems and improve diagnostic capabilities. This includes investing in specialized laboratories, surveillance mechanisms, and funding to support the implementation of national strategies.
The fight against antimicrobial resistance requires a coordinated global response. The WHO's report underscores the importance of collaboration and knowledge-sharing to address this complex public health issue and preserve the effectiveness of antimicrobials.
Key points
- The WHO reports that only 36% of countries have a national reference laboratory capable of analyzing bacteria and fungi related to antimicrobial resistance.
- Despite progress in adopting national strategies, only 22% of countries have mobilized necessary funding and fully executed their action plans.
- In 2023, nearly one in six laboratory-confirmed bacterial infections worldwide showed resistance to antibiotics.